A postulated mechanism for deletions with inversions.

Por Sommer, S S, Ketterling, R P
Publicado em 1993

Are some apparently simple deletions actually two concerted deletions that result from interacting RY(i) hairpin loops?

Por Ketterling, R P, Liao, D, Sommer, S S
Publicado em 1995

The rates of G:C-->T:A and G:C-->C:G transversions at CpG dinucleotides in the human factor IX gene.

Por Ketterling, R. P., Vielhaber, E., Sommer, S. S.
Publicado em 1994

PRE: a novel element with the hallmarks of a retrotransposon derived from an unknown structural RNA.

Por Ricke, D O, Ketterling, R P, Sommer, S S
Publicado em 1992

The pattern of factor IX germ-line mutation in Asians is similar to that of Caucasians.

Por Bottema, C D, Ketterling, R P, Yoon, H S, Sommer, S S
Publicado em 1990

Hemophilia B in a male with a four-base insertion that arose in the germline of his mother.

Por Bottema, C D, Ketterling, R P, Cho, H I, Sommer, S S
Publicado em 1989

Mutations at arginine residues in two Asian hemophilia B patients.

Por Bottema, C D, Ketterling, R P, Koeberl, D D, Taylor, S A, Sommer, S S
Publicado em 1990

The rates and patterns of deletions in the human factor IX gene.

Por Ketterling, R. P., Vielhaber, E. L., Lind, T. J., Thorland, E. C., Sommer, S. S.
Publicado em 1994

Missense mutations and evolutionary conservation of amino acids: evidence that many of the amino acids in factor IX function as "spacer" elements.

Por Bottema, C D, Ketterling, R P, Ii, S, Yoon, H S, Phillips, J A, Sommer, S S
Publicado em 1991

Application of current prognostic models for primary myelofibrosis in the setting of post-polycythemia vera or post-essential thrombocythemia myelofibrosis

Por Tefferi, A, Saeed, L, Hanson, C A, Ketterling, R P, Pardanani, A, Gangat, N
Publicado no Leukemia (2017)

Prognostic impact of bone marrow fibrosis in polycythemia vera: validation of the IWG-MRT study and additional observations

Por Barraco, D, Cerquozzi, S, Hanson, C A, Ketterling, R P, Pardanani, A, Gangat, N, Tefferi, A
Publicado no Blood Cancer J (2017)

Mutations causing hemophilia B: direct estimate of the underlying rates of spontaneous germ-line transitions, transversions, and deletions in a human gene.

Por Koeberl, D D, Bottema, C D, Ketterling, R P, Bridge, P J, Lillicrap, D P, Sommer, S S
Publicado em 1990

Liver function test abnormalities and their clinical relevance in primary myelofibrosis

Por Barraco, D, Mudireddy, M, Shah, S, Hanson, C A, Ketterling, R P, Gangat, N, Pardanani, A, Tefferi, A
Publicado no Blood Cancer J (2017)

Germ-line origins of mutation in families with hemophilia B: the sex ratio varies with the type of mutation.

Por Ketterling, R P, Vielhaber, E, Bottema, C D, Schaid, D J, Cohen, M P, Sexauer, C L, Sommer, S S
Publicado em 1993

Why does the human factor IX gene have a G + C content of 40%?

Por Bottema, C D, Bottema, M J, Ketterling, R P, Yoon, H S, Janco, R L, Phillips, J A, Sommer, S S
Publicado em 1991

Risk factors for arterial versus venous thrombosis in polycythemia vera: a single center experience in 587 patients

Por Cerquozzi, S., Barraco, D., Lasho, T., Finke, C., Hanson, C. A., Ketterling, R. P., Pardanani, A., Gangat, N., Tefferi, A.
Publicado no Blood Cancer J (2017)

Prognostic interaction between ASXL1 and TET2 mutations in chronic myelomonocytic leukemia

Por Patnaik, M M, Lasho, T L, Vijayvargiya, P, Finke, C M, Hanson, C A, Ketterling, R P, Gangat, N, Tefferi, A
Publicado no Blood Cancer J (2016)

Novel recurrent mutations in ethanolamine kinase 1 (ETNK1) gene in systemic mastocytosis with eosinophilia and chronic myelomonocytic leukemia

Por Lasho, T L, Finke, C M, Zblewski, D, Patnaik, M, Ketterling, R P, Chen, D, Hanson, C A, Tefferi, A, Pardanani, A
Publicado no Blood Cancer J (2015)

Connective tissue dysplasia in five new patients with NF1 microdeletions: further expansion of phenotype and review of the literature

Por Mensink, K A, Ketterling, R P, Flynn, H C, Knudson, R A, Lindor, N M, Heese, B A, Spinner, R J, Babovic‐Vuksanovic, D
Publicado em 2006

SETBP1 mutations in 415 patients with primary myelofibrosis or chronic myelomonocytic leukemia: independent prognostic impact in CMML

Por Laborde, R R, Patnaik, M M, Lasho, T L, Finke, C M, Hanson, C A, Knudson, R A, Ketterling, R P, Pardanani, A, Tefferi, A
Publicado em 2013